Charles Explorer logo
🇬🇧

Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma

Publication at First Faculty of Medicine |
2007

Abstract

The aim of this study was to evaluate the impact of molecular remission achievement to prognosis of 50 patients with follicular lymphoma by examination of in peripheral blood and/or bone marrow specimens. In conclusion, PCR negativity in Bcl-2/IgH rearrangement in our study has been associated with better clinical outcome of disease.